LLMpediaThe first transparent, open encyclopedia generated by LLMs

Exactech

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Asensus Surgical Hop 4
Expansion Funnel Raw 54 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted54
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Exactech
NameExactech
TypePublic
IndustryMedical devices
Founded1985
FoundersWilliam Maloney, Scott D. Peltz
HeadquartersGainesville, Florida
ProductsOrthopaedic implants, surgical instrumentation, polyethylene inserts
Revenue(varies; publicly reported)
Website(company website)

Exactech is a multinational medical device manufacturer specializing in orthopaedic implants, instrumentation, and biomaterials for joint replacement procedures. The company develops hip, knee, ankle, and spine systems used by surgeons in hospital and ambulatory surgery settings. Exactech has operated in the global orthopaedics market alongside manufacturers such as Zimmer Biomet, Stryker, DePuy Synthes, Smith & Nephew, and Medtronic while interacting with regulatory agencies including the Food and Drug Administration and the European Medicines Agency.

History

Exactech was founded in 1985 in Gainesville, Florida during a period of rapid innovation in orthopaedic implants driven by developments at institutions like the Mayo Clinic and Johns Hopkins Hospital. Early growth involved collaboration with academic surgeons affiliated with University of Florida and device researchers tied to Cleveland Clinic and Massachusetts General Hospital. Through the 1990s and 2000s the firm expanded product lines and distribution networks, engaging with orthopaedic societies such as the American Academy of Orthopaedic Surgeons and participating in meetings like the American Association of Hip and Knee Surgeons annual congresses. Exactech’s corporate trajectory included public offerings, strategic hires from companies such as Zimmer Holdings and Biomet and commercial expansion into markets regulated by agencies like the Medicines and Healthcare products Regulatory Agency in the United Kingdom and health authorities in Canada, Australia, and countries across Europe and Asia.

Products and Technology

Exactech’s portfolio has encompassed total and partial joint arthroplasty systems for hip, knee, and ankle applications plus spine implants and biologic adjuncts. Key product families were designed for procedures performed by surgeons trained at centers like Hospital for Special Surgery and Mayo Clinic and used instrumentation workflows influenced by navigation and robotic platforms such as MAKO Surgical technology and systems from Intuitive Surgical in adjacent specialties. The company manufactured polyethylene tibial inserts, femoral components, acetabular cups, and ankle implants intended to address osteoarthritis treated by clinicians affiliated with institutions like Cleveland Clinic Foundation and Mount Sinai Hospital. Materials science efforts paralleled work at universities including Stanford University and Massachusetts Institute of Technology on crosslinked polyethylene, vitamin E–stabilized polymers, and novel sterilization techniques. Exactech also produced surgical trays and proprietary instrumentation for operating rooms at hospitals like Johns Hopkins Hospital and devices used by surgeons associated with the American Orthopaedic Foot & Ankle Society.

Quality Control and Safety Issues

Exactech faced scrutiny over implant performance and packaging integrity in connection with polyethylene wear and oxidation concerns observed by revision surgeons at centers such as Hospital for Special Surgery and Mayo Clinic. Reports of early device-related failures prompted investigations by clinical registries like the National Joint Registry and publications in journals associated with organizations such as the American Journal of Orthopaedics and Journal of Arthroplasty. Questions focused on manufacturing processes, sterilization methods referenced in materials science work at institutions like Johns Hopkins University, and packaging that may have allowed oxygen ingress similar to scenarios described in studies from Wake Forest School of Medicine. Surgeons from academic centers including Vanderbilt University Medical Center and University of California, San Francisco contributed case series raising alarms about higher-than-expected revision rates tied to particular implant lots. Those clinical observations led to advisories and product actions that mobilized hospital risk-management teams at institutions such as Cleveland Clinic.

The company responded to safety concerns with recalls and customer communications overseen by regulators including the Food and Drug Administration and national competent authorities across Europe. Litigation followed in several jurisdictions, with plaintiffs represented by law firms that regularly litigate medical device matters against corporations like Johnson & Johnson and Boston Scientific. Class actions and multidistrict litigation panels addressed allegations of defective devices, disclosure lapses, and claims for revision surgery costs; courts in states such as Florida and New York handled related filings. Regulatory correspondence and enforcement actions invoked standards set forth by agencies like the European Commission for medical devices and the FDA's device reporting and recall frameworks. Settlements, ongoing civil cases, and continued regulatory oversight mirrored precedents set in high-profile device litigations involving manufacturers such as Stryker and DePuy Synthes.

Corporate Governance and Operations

Exactech’s governance structure included a board of directors and executive leadership with backgrounds from companies like Zimmer Biomet, Stryker, and Medtronic. Operationally, the firm maintained manufacturing, distribution, and quality units to serve hospitals and ambulatory surgery centers such as Cleveland Clinic and Mayo Clinic Health System while coordinating with global distributors in regions including Europe, Asia, and Latin America. The company engaged with professional societies including the American Academy of Orthopaedic Surgeons and the International Society for Technology in Arthroplasty for clinician education and product training. Financial reporting and shareholder relations reflected public-company practices similar to those of peers listed on exchanges where other medical device firms such as Stryker Corporation and Zimmer Biomet Holdings disclose performance. Ongoing operational priorities included supply-chain resilience, quality management system enhancements, and compliance with standards promulgated by organizations like International Organization for Standardization and regulatory agencies including the FDA.

Category:Medical device companies